-
1
-
-
53649102120
-
History of immunoglobulin replacement
-
viii
-
Eibl M.M. History of immunoglobulin replacement. Immunol Allergy Clin North Am 2008, 28(4):737-764. viii.
-
(2008)
Immunol Allergy Clin North Am
, vol.28
, Issue.4
, pp. 737-764
-
-
Eibl, M.M.1
-
2
-
-
0036228218
-
In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations-a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases
-
Krause I., Wu R., Sherer Y., et al. In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations-a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases. Transfus Med 2002, 12(2):133-139.
-
(2002)
Transfus Med
, vol.12
, Issue.2
, pp. 133-139
-
-
Krause, I.1
Wu, R.2
Sherer, Y.3
-
3
-
-
72149111128
-
Intravenous immunoglobulins-understanding properties and mechanisms
-
Durandy A., Kaveri S.V., Kuijpers T.W., et al. Intravenous immunoglobulins-understanding properties and mechanisms. Clin Exp Immunol 2009, 158(Suppl 1):2-13.
-
(2009)
Clin Exp Immunol
, vol.158
, Issue.SUPPL. 1
, pp. 2-13
-
-
Durandy, A.1
Kaveri, S.V.2
Kuijpers, T.W.3
-
4
-
-
54749099644
-
Unlabeled uses of intravenous immune globulin
-
Leong H., Stachnik J., Bonk M.E., et al. Unlabeled uses of intravenous immune globulin. Am J Health Syst Pharm 2008, 65(19):1815-1824.
-
(2008)
Am J Health Syst Pharm
, vol.65
, Issue.19
, pp. 1815-1824
-
-
Leong, H.1
Stachnik, J.2
Bonk, M.E.3
-
5
-
-
33645341439
-
Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology
-
Orange J.S., Hossny E.M., Weiler C.R., et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2006, 117(Suppl 4):S525-S553.
-
(2006)
J Allergy Clin Immunol
, vol.117
, Issue.SUPPL. 4
-
-
Orange, J.S.1
Hossny, E.M.2
Weiler, C.R.3
-
6
-
-
33646249914
-
Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature
-
Darabi K., Abdel-Wahab O., Dzik W.H. Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature. Transfusion 2006, 46(5):741-753.
-
(2006)
Transfusion
, vol.46
, Issue.5
, pp. 741-753
-
-
Darabi, K.1
Abdel-Wahab, O.2
Dzik, W.H.3
-
7
-
-
33748057490
-
Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation
-
Sriskandan S., Ferguson M., Elliot V., et al. Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation. J Antimicrob Chemother 2006, 58(1):117-124.
-
(2006)
J Antimicrob Chemother
, vol.58
, Issue.1
, pp. 117-124
-
-
Sriskandan, S.1
Ferguson, M.2
Elliot, V.3
-
8
-
-
0035004294
-
Pathophysiology of septic shock and multiple organ dysfunction syndrome and various therapeutic approaches with special emphasis on immunoglobulins
-
Werdan K. Pathophysiology of septic shock and multiple organ dysfunction syndrome and various therapeutic approaches with special emphasis on immunoglobulins. Ther Apher 2001, 5(2):115-122.
-
(2001)
Ther Apher
, vol.5
, Issue.2
, pp. 115-122
-
-
Werdan, K.1
-
9
-
-
36448938357
-
Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock
-
Kreymann K.G., de Heer G., Nierhaus A., et al. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med 2007, 35(12):2677-2685.
-
(2007)
Crit Care Med
, vol.35
, Issue.12
, pp. 2677-2685
-
-
Kreymann, K.G.1
de Heer, G.2
Nierhaus, A.3
-
10
-
-
33847009520
-
Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis
-
Turgeon A.F., Hutton B., Fergusson D.A., et al. Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Ann Intern Med 2007, 146(3):193-203.
-
(2007)
Ann Intern Med
, vol.146
, Issue.3
, pp. 193-203
-
-
Turgeon, A.F.1
Hutton, B.2
Fergusson, D.A.3
-
11
-
-
36448996190
-
Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis
-
Laupland K.B., Kirkpatrick A.W., Delaney A. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med 2007, 35(12):2686-2692.
-
(2007)
Crit Care Med
, vol.35
, Issue.12
, pp. 2686-2692
-
-
Laupland, K.B.1
Kirkpatrick, A.W.2
Delaney, A.3
-
13
-
-
16244362082
-
Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery
-
Rodriguez A., Rello J., Neira J., et al. Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery. Shock 2005, 23(4):298-304.
-
(2005)
Shock
, vol.23
, Issue.4
, pp. 298-304
-
-
Rodriguez, A.1
Rello, J.2
Neira, J.3
-
14
-
-
0035048611
-
Treatment of sepsis in cardiac surgery: role of immunoglobulins
-
Sablotzki A., Muhling J., Dehne M.G., et al. Treatment of sepsis in cardiac surgery: role of immunoglobulins. Perfusion 2001, 16(2):113-120.
-
(2001)
Perfusion
, vol.16
, Issue.2
, pp. 113-120
-
-
Sablotzki, A.1
Muhling, J.2
Dehne, M.G.3
-
15
-
-
0028128048
-
Early sepsis treatment with immunoglobulins after cardiac surgery in score-identified high-risk patients
-
Pilz G., Kreuzer E., Kaab S., et al. Early sepsis treatment with immunoglobulins after cardiac surgery in score-identified high-risk patients. Chest 1994, 105(1):76-82.
-
(1994)
Chest
, vol.105
, Issue.1
, pp. 76-82
-
-
Pilz, G.1
Kreuzer, E.2
Kaab, S.3
-
16
-
-
0026647438
-
Intravenous immunoglobulin therapy for toxic shock syndrome
-
Barry W., Hudgins L., Donta S.T., et al. Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA 1992, 267(24):3315-3316.
-
(1992)
JAMA
, vol.267
, Issue.24
, pp. 3315-3316
-
-
Barry, W.1
Hudgins, L.2
Donta, S.T.3
-
17
-
-
0032924155
-
Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. The Canadian Streptococcal Study Group
-
Kaul R., McGeer A., Norrby-Teglund A., et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 1999, 28(4):800-807.
-
(1999)
Clin Infect Dis
, vol.28
, Issue.4
, pp. 800-807
-
-
Kaul, R.1
McGeer, A.2
Norrby-Teglund, A.3
-
18
-
-
0032014832
-
Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome
-
Stevens D.L. Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome. Clin Infect Dis 1998, 26(3):639-641.
-
(1998)
Clin Infect Dis
, vol.26
, Issue.3
, pp. 639-641
-
-
Stevens, D.L.1
-
19
-
-
0041402681
-
Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial
-
Darenberg J., Ihendyane N., Sjolin J., et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003, 37(3):333-340.
-
(2003)
Clin Infect Dis
, vol.37
, Issue.3
, pp. 333-340
-
-
Darenberg, J.1
Ihendyane, N.2
Sjolin, J.3
-
20
-
-
72849139516
-
Intravenous immunoglobulin in children with streptococcal toxic shock syndrome
-
Shah S.S., Hall M., Srivastava R., et al. Intravenous immunoglobulin in children with streptococcal toxic shock syndrome. Clin Infect Dis 2009, 49(9):1369-1376.
-
(2009)
Clin Infect Dis
, vol.49
, Issue.9
, pp. 1369-1376
-
-
Shah, S.S.1
Hall, M.2
Srivastava, R.3
-
21
-
-
1642319406
-
Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome
-
Darenberg J., Soderquist B., Normark B.H., et al. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome. Clin Infect Dis 2004, 38(6):836-842.
-
(2004)
Clin Infect Dis
, vol.38
, Issue.6
, pp. 836-842
-
-
Darenberg, J.1
Soderquist, B.2
Normark, B.H.3
-
22
-
-
2442464696
-
Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001
-
Archibald L.K., Banerjee S.N., Jarvis W.R. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 2004, 189(9):1585-1589.
-
(2004)
J Infect Dis
, vol.189
, Issue.9
, pp. 1585-1589
-
-
Archibald, L.K.1
Banerjee, S.N.2
Jarvis, W.R.3
-
23
-
-
4344559215
-
Factors associated with failure of metronidazole in Clostridium difficile-associated disease
-
Fernandez A., Anand G., Friedenberg F. Factors associated with failure of metronidazole in Clostridium difficile-associated disease. J Clin Gastroenterol 2004, 38(5):414-418.
-
(2004)
J Clin Gastroenterol
, vol.38
, Issue.5
, pp. 414-418
-
-
Fernandez, A.1
Anand, G.2
Friedenberg, F.3
-
24
-
-
0036467063
-
Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile
-
Kyne L., Hamel M.B., Polavaram R., et al. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002, 34(3):346-353.
-
(2002)
Clin Infect Dis
, vol.34
, Issue.3
, pp. 346-353
-
-
Kyne, L.1
Hamel, M.B.2
Polavaram, R.3
-
25
-
-
0023503051
-
Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters
-
Kim P.H., Iaconis J.P., Rolfe R.D. Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters. Infect Immun 1987, 55(12):2984-2992.
-
(1987)
Infect Immun
, vol.55
, Issue.12
, pp. 2984-2992
-
-
Kim, P.H.1
Iaconis, J.P.2
Rolfe, R.D.3
-
26
-
-
0025804091
-
Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate
-
Lyerly D.M., Bostwick E.F., Binion S.B., et al. Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate. Infect Immun 1991, 59(6):2215-2218.
-
(1991)
Infect Immun
, vol.59
, Issue.6
, pp. 2215-2218
-
-
Lyerly, D.M.1
Bostwick, E.F.2
Binion, S.B.3
-
27
-
-
78649807947
-
Management of Clostridium difficile infection: thinking inside and outside the box
-
Gerding D.N., Johnson S. Management of Clostridium difficile infection: thinking inside and outside the box. Clin Infect Dis 2010, 51(11):1306-1313.
-
(2010)
Clin Infect Dis
, vol.51
, Issue.11
, pp. 1306-1313
-
-
Gerding, D.N.1
Johnson, S.2
-
28
-
-
0034628426
-
Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A
-
Kyne L., Warny M., Qamar A., et al. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000, 342(6):390-397.
-
(2000)
N Engl J Med
, vol.342
, Issue.6
, pp. 390-397
-
-
Kyne, L.1
Warny, M.2
Qamar, A.3
-
29
-
-
79151476267
-
Intravenous immunoglobulin for the treatment of Clostridium difficile infection: a review
-
Abougergi M.S., Kwon J.H. Intravenous immunoglobulin for the treatment of Clostridium difficile infection: a review. Dig Dis Sci 2011, 56(1):19-26.
-
(2011)
Dig Dis Sci
, vol.56
, Issue.1
, pp. 19-26
-
-
Abougergi, M.S.1
Kwon, J.H.2
-
30
-
-
70349491503
-
The role of immunoglobulin for the treatment of Clostridium difficile infection: a systematic review
-
O'Horo J., Safdar N. The role of immunoglobulin for the treatment of Clostridium difficile infection: a systematic review. Int J Infect Dis 2009, 13(6):663-667.
-
(2009)
Int J Infect Dis
, vol.13
, Issue.6
, pp. 663-667
-
-
O'Horo, J.1
Safdar, N.2
-
31
-
-
0030763467
-
Intravenous immunoglobulin therapy for severe Clostridium difficile colitis
-
Salcedo J., Keates S., Pothoulakis C., et al. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut 1997, 41(3):366-370.
-
(1997)
Gut
, vol.41
, Issue.3
, pp. 366-370
-
-
Salcedo, J.1
Keates, S.2
Pothoulakis, C.3
-
32
-
-
74849098405
-
Treatment with monoclonal antibodies against Clostridium difficile toxins
-
Lowy I., Molrine D.C., Leav B.A., et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med 2010, 362(3):197-205.
-
(2010)
N Engl J Med
, vol.362
, Issue.3
, pp. 197-205
-
-
Lowy, I.1
Molrine, D.C.2
Leav, B.A.3
-
33
-
-
84925549068
-
Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel
-
Kretsinger K., Broder K.R., Cortese M.M., et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 2006, 55(RR-17):1-37.
-
(2006)
MMWR Recomm Rep
, vol.55
, Issue.17
, pp. 1-37
-
-
Kretsinger, K.1
Broder, K.R.2
Cortese, M.M.3
-
34
-
-
79954508220
-
Centers for Disease Control and Prevention (CDC) Tetanus surveillance-United States, 2001-2008
-
Centers for Disease Control and Prevention (CDC) Tetanus surveillance-United States, 2001-2008. MMWR Morb Mortal Wkly Rep 2011, 60(12):365-369.
-
(2011)
MMWR Morb Mortal Wkly Rep
, vol.60
, Issue.12
, pp. 365-369
-
-
-
35
-
-
79952235043
-
Narrative review: tetanus-a health threat after natural disasters in developing countries
-
Afshar M., Raju M., Ansell D., et al. Narrative review: tetanus-a health threat after natural disasters in developing countries. Ann Intern Med 2011, 154(5):329-335.
-
(2011)
Ann Intern Med
, vol.154
, Issue.5
, pp. 329-335
-
-
Afshar, M.1
Raju, M.2
Ansell, D.3
-
36
-
-
0033793926
-
Passive immunity in prevention and treatment of infectious diseases
-
Keller M.A., Stiehm E.R. Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev 2000, 13(4):602-614.
-
(2000)
Clin Microbiol Rev
, vol.13
, Issue.4
, pp. 602-614
-
-
Keller, M.A.1
Stiehm, E.R.2
-
37
-
-
77949581390
-
Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E
-
Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E. MMWR Morb Mortal Wkly Rep 2010, 59(10):299.
-
(2010)
MMWR Morb Mortal Wkly Rep
, vol.59
, Issue.10
, pp. 299
-
-
-
38
-
-
80455171781
-
-
Organization WH. WHO vaccine-preventable diseases monitoring system: 2010 global summary, Geneva (Switzerland): World Health Organization;
-
Organization WH. WHO vaccine-preventable diseases monitoring system: 2010 global summary, vol. 2. Geneva (Switzerland): World Health Organization; 2010. p. R-234.
-
(2010)
, vol.2
-
-
-
40
-
-
34547648810
-
Centers for Disease Control and Prevention (CDC) Availability of diphtheria antitoxin through an investigational new drug protocol
-
Centers for Disease Control and Prevention (CDC) Availability of diphtheria antitoxin through an investigational new drug protocol. MMWR Morb Mortal Wkly Rep 1997, 46(17):380.
-
(1997)
MMWR Morb Mortal Wkly Rep
, vol.46
, Issue.17
, pp. 380
-
-
-
41
-
-
0023266643
-
Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients
-
Snydman D.R., Werner B.G., Heinze-Lacey B., et al. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med 1987, 317(17):1049-1054.
-
(1987)
N Engl J Med
, vol.317
, Issue.17
, pp. 1049-1054
-
-
Snydman, D.R.1
Werner, B.G.2
Heinze-Lacey, B.3
-
42
-
-
0027483992
-
Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial
-
Snydman D.R., Werner B.G., Dougherty N.N., et al. Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1993, 119(10):984-991.
-
(1993)
Ann Intern Med
, vol.119
, Issue.10
, pp. 984-991
-
-
Snydman, D.R.1
Werner, B.G.2
Dougherty, N.N.3
-
43
-
-
36249015226
-
Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients
-
CD005129
-
Hodson E.M., Jones C.A., Strippoli G.F., et al. Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev 2007, 2. CD005129.
-
(2007)
Cochrane Database Syst Rev
, vol.2
-
-
Hodson, E.M.1
Jones, C.A.2
Strippoli, G.F.3
-
44
-
-
72949103510
-
Cytomegalovirus in solid organ transplant recipients
-
Humar A., Snydman D. Cytomegalovirus in solid organ transplant recipients. Am J Transplant 2009, 9(Suppl 4):S78-S86.
-
(2009)
Am J Transplant
, vol.9
, Issue.SUPPL. 4
-
-
Humar, A.1
Snydman, D.2
-
45
-
-
77957280871
-
An international survey of cytomegalovirus management practices in lung transplantation
-
Zuk D.M., Humar A., Weinkauf J.G., et al. An international survey of cytomegalovirus management practices in lung transplantation. Transplantation 2010, 90(6):672-676.
-
(2010)
Transplantation
, vol.90
, Issue.6
, pp. 672-676
-
-
Zuk, D.M.1
Humar, A.2
Weinkauf, J.G.3
-
46
-
-
34548703848
-
The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections
-
Carbone J., Sarmiento E., Palomo J., et al. The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections. Transplant Proc 2007, 39(7):2385-2388.
-
(2007)
Transplant Proc
, vol.39
, Issue.7
, pp. 2385-2388
-
-
Carbone, J.1
Sarmiento, E.2
Palomo, J.3
-
47
-
-
77950926374
-
International consensus guidelines on the management of cytomegalovirus in solid organ transplantation
-
Kotton C.N., Kumar D., Caliendo A.M., et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010, 89(7):779-795.
-
(2010)
Transplantation
, vol.89
, Issue.7
, pp. 779-795
-
-
Kotton, C.N.1
Kumar, D.2
Caliendo, A.M.3
-
48
-
-
0022575268
-
Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation
-
Bowden R.A., Sayers M., Flournoy N., et al. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 1986, 314(16):1006-1010.
-
(1986)
N Engl J Med
, vol.314
, Issue.16
, pp. 1006-1010
-
-
Bowden, R.A.1
Sayers, M.2
Flournoy, N.3
-
49
-
-
0021281394
-
Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin. Randomized trial in bone marrow transplant recipients
-
Condie R.M., O'Reilly R.J. Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin. Randomized trial in bone marrow transplant recipients. Am J Med 1984, 76(3A):134-141.
-
(1984)
Am J Med
, vol.76
, Issue.3
, pp. 134-141
-
-
Condie, R.M.1
O'Reilly, R.J.2
-
50
-
-
59949103959
-
Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis
-
Raanani P., Gafter-Gvili A., Paul M., et al. Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis. J Clin Oncol 2009, 27(5):770-781.
-
(2009)
J Clin Oncol
, vol.27
, Issue.5
, pp. 770-781
-
-
Raanani, P.1
Gafter-Gvili, A.2
Paul, M.3
-
51
-
-
0023144913
-
Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation
-
Winston D.J., Ho W.G., Lin C.H., et al. Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med 1987, 106(1):12-18.
-
(1987)
Ann Intern Med
, vol.106
, Issue.1
, pp. 12-18
-
-
Winston, D.J.1
Ho, W.G.2
Lin, C.H.3
-
52
-
-
0038819950
-
Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial
-
Cordonnier C., Chevret S., Legrand M., et al. Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial. Ann Intern Med 2003, 139(1):8-18.
-
(2003)
Ann Intern Med
, vol.139
, Issue.1
, pp. 8-18
-
-
Cordonnier, C.1
Chevret, S.2
Legrand, M.3
-
53
-
-
0024514532
-
Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir
-
Verdonck L.F., de Gast G.C., Dekker A.W., et al. Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir. Bone Marrow Transplant 1989, 4(2):187-189.
-
(1989)
Bone Marrow Transplant
, vol.4
, Issue.2
, pp. 187-189
-
-
Verdonck, L.F.1
de Gast, G.C.2
Dekker, A.W.3
-
54
-
-
0024232608
-
Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants
-
Reed E.C., Bowden R.A., Dandliker P.S., et al. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med 1988, 109(10):783-788.
-
(1988)
Ann Intern Med
, vol.109
, Issue.10
, pp. 783-788
-
-
Reed, E.C.1
Bowden, R.A.2
Dandliker, P.S.3
-
55
-
-
77952946091
-
Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipients
-
Alexander B.T., Hladnik L.M., Augustin K.M., et al. Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipients. Pharmacotherapy 2010, 30(6):554-561.
-
(2010)
Pharmacotherapy
, vol.30
, Issue.6
, pp. 554-561
-
-
Alexander, B.T.1
Hladnik, L.M.2
Augustin, K.M.3
-
56
-
-
0024230867
-
Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin
-
Emanuel D., Cunningham I., Jules-Elysee K., et al. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann Intern Med 1988, 109(10):777-782.
-
(1988)
Ann Intern Med
, vol.109
, Issue.10
, pp. 777-782
-
-
Emanuel, D.1
Cunningham, I.2
Jules-Elysee, K.3
-
57
-
-
0001484781
-
The etiology of infectious hepatitis
-
[discussion: 676-9]
-
Havens W.P. The etiology of infectious hepatitis. J Am Med Assoc 1947, 134(8):653-655. [discussion: 676-9].
-
(1947)
J Am Med Assoc
, vol.134
, Issue.8
, pp. 653-655
-
-
Havens, W.P.1
-
58
-
-
77049221672
-
Use of gamma globulin for control of infectious hepatitis in an institution for the mentally retarded
-
Ashley A. Use of gamma globulin for control of infectious hepatitis in an institution for the mentally retarded. N Engl J Med 1955, 252(3):88-91.
-
(1955)
N Engl J Med
, vol.252
, Issue.3
, pp. 88-91
-
-
Ashley, A.1
-
59
-
-
35348976213
-
Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC) Update: prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP)
-
Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC) Update: prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2007, 56(41):1080-1084.
-
(2007)
MMWR Morb Mortal Wkly Rep
, vol.56
, Issue.41
, pp. 1080-1084
-
-
-
60
-
-
33646715581
-
Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)
-
Fiore A.E., Wasley A., Bell B.P. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006, 55(RR-7):1-23.
-
(2006)
MMWR Recomm Rep
, vol.55
, Issue.7
, pp. 1-23
-
-
Fiore, A.E.1
Wasley, A.2
Bell, B.P.3
-
62
-
-
35548959176
-
Hepatitis A vaccine versus immune globulin for postexposure prophylaxis
-
Victor J.C., Monto A.S., Surdina T.Y., et al. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med 2007, 357(17):1685-1694.
-
(2007)
N Engl J Med
, vol.357
, Issue.17
, pp. 1685-1694
-
-
Victor, J.C.1
Monto, A.S.2
Surdina, T.Y.3
-
63
-
-
39049191182
-
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults
-
[quiz: CE31-4]
-
Mast E.E., Weinbaum C.M., Fiore A.E., et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006, 55(RR-16):1-33. [quiz: CE31-4].
-
(2006)
MMWR Recomm Rep
, vol.55
, Issue.16
, pp. 1-33
-
-
Mast, E.E.1
Weinbaum, C.M.2
Fiore, A.E.3
-
64
-
-
0024341965
-
Combined hepatitis B immune globulin and vaccine for postexposure prophylaxis of accidental hepatitis B virus infection in hemodialysis staff members: comparison with immune globulin without vaccine in historical controls
-
Mitsui T., Iwano K., Suzuki S., et al. Combined hepatitis B immune globulin and vaccine for postexposure prophylaxis of accidental hepatitis B virus infection in hemodialysis staff members: comparison with immune globulin without vaccine in historical controls. Hepatology 1989, 10(3):324-327.
-
(1989)
Hepatology
, vol.10
, Issue.3
, pp. 324-327
-
-
Mitsui, T.1
Iwano, K.2
Suzuki, S.3
-
65
-
-
0021908344
-
Post-exposure active immunoprophylaxis of spouses of acute viral hepatitis B patients
-
Roumeliotou-Karayannis A., Papaevangelou G., Tassopoulos N., et al. Post-exposure active immunoprophylaxis of spouses of acute viral hepatitis B patients. Vaccine 1985, 3(1):31-34.
-
(1985)
Vaccine
, vol.3
, Issue.1
, pp. 31-34
-
-
Roumeliotou-Karayannis, A.1
Papaevangelou, G.2
Tassopoulos, N.3
-
66
-
-
0018177459
-
Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial
-
Grady G.F., Lee V.A., Prince A.M., et al. Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis 1978, 138(5):625-638.
-
(1978)
J Infect Dis
, vol.138
, Issue.5
, pp. 625-638
-
-
Grady, G.F.1
Lee, V.A.2
Prince, A.M.3
-
67
-
-
0016784820
-
Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis
-
Redeker A.G., Mosley J.W., Gocke D.J., et al. Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis. N Engl J Med 1975, 293(21):1055-1059.
-
(1975)
N Engl J Med
, vol.293
, Issue.21
, pp. 1055-1059
-
-
Redeker, A.G.1
Mosley, J.W.2
Gocke, D.J.3
-
68
-
-
0017878739
-
Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study
-
Seeff L.B., Wright E.C., Zimmerman H.J., et al. Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. Ann Intern Med 1978, 88(3):285-293.
-
(1978)
Ann Intern Med
, vol.88
, Issue.3
, pp. 285-293
-
-
Seeff, L.B.1
Wright, E.C.2
Zimmerman, H.J.3
-
69
-
-
77955481931
-
Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation
-
CD006005
-
Katz L.H., Tur-Kaspa R., Guy D.G., et al. Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation. Cochrane Database Syst Rev 2010, 7. CD006005.
-
(2010)
Cochrane Database Syst Rev
, vol.7
-
-
Katz, L.H.1
Tur-Kaspa, R.2
Guy, D.G.3
-
70
-
-
77951737280
-
Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: a systematic review
-
Chen J., Yi L., Jia J.D., et al. Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: a systematic review. J Gastroenterol Hepatol 2010, 25(5):872-879.
-
(2010)
J Gastroenterol Hepatol
, vol.25
, Issue.5
, pp. 872-879
-
-
Chen, J.1
Yi, L.2
Jia, J.D.3
-
71
-
-
0018162641
-
Antibody to varicella-zoster virus after passive immunization against chickenpox
-
Gershon A.A., Piomelli S., Karpatkin M., et al. Antibody to varicella-zoster virus after passive immunization against chickenpox. J Clin Microbiol 1978, 8(6):733-735.
-
(1978)
J Clin Microbiol
, vol.8
, Issue.6
, pp. 733-735
-
-
Gershon, A.A.1
Piomelli, S.2
Karpatkin, M.3
-
72
-
-
0021085162
-
Zoster immunoglobulin in varicella prophylaxis. A study among high-risk patients
-
Hanngren K., Falksveden L., Grandien M., et al. Zoster immunoglobulin in varicella prophylaxis. A study among high-risk patients. Scand J Infect Dis 1983, 15(4):327-334.
-
(1983)
Scand J Infect Dis
, vol.15
, Issue.4
, pp. 327-334
-
-
Hanngren, K.1
Falksveden, L.2
Grandien, M.3
-
73
-
-
0030581083
-
Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention
-
Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep 1996, 45(RR-11):1-36.
-
(1996)
MMWR Recomm Rep
, vol.45
, Issue.11
, pp. 1-36
-
-
-
74
-
-
34250688647
-
Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)
-
Marin M., Guris D., Chaves S.S., et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007, 56(RR-4):1-40.
-
(2007)
MMWR Recomm Rep
, vol.56
, Issue.4
, pp. 1-40
-
-
Marin, M.1
Guris, D.2
Chaves, S.S.3
-
75
-
-
0021279137
-
Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin
-
Paryani S.G., Arvin A.M., Koropchak C.M., et al. Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin. Am J Med 1984, 76(3A):124-127.
-
(1984)
Am J Med
, vol.76
, Issue.3
, pp. 124-127
-
-
Paryani, S.G.1
Arvin, A.M.2
Koropchak, C.M.3
-
76
-
-
0008048635
-
Laboratory data supporting the clinical trial of anti-rabies serum in persons bitten by a rabid wolf
-
Habel K., Koprowski H. Laboratory data supporting the clinical trial of anti-rabies serum in persons bitten by a rabid wolf. Bull World Health Organ 1955, 13(5):773-779.
-
(1955)
Bull World Health Organ
, vol.13
, Issue.5
, pp. 773-779
-
-
Habel, K.1
Koprowski, H.2
-
77
-
-
0024119409
-
Use of serum and vaccine in combination for prophylaxis following exposure to rabies
-
Lin F.T., Chen S.B., Wang Y.Z., et al. Use of serum and vaccine in combination for prophylaxis following exposure to rabies. Rev Infect Dis 1988, 10(Suppl 4):S766-S770.
-
(1988)
Rev Infect Dis
, vol.10
, Issue.SUPPL. 4
-
-
Lin, F.T.1
Chen, S.B.2
Wang, Y.Z.3
-
78
-
-
0029990164
-
What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously?
-
Khawplod P., Wilde H., Chomchey P., et al. What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously?. Vaccine 1996, 14(5):389-391.
-
(1996)
Vaccine
, vol.14
, Issue.5
, pp. 389-391
-
-
Khawplod, P.1
Wilde, H.2
Chomchey, P.3
-
79
-
-
44349123571
-
Human rabies prevention-United States, 2008: recommendations of the Advisory Committee on Immunization Practices
-
Manning S.E., Rupprecht C.E., Fishbein D., et al. Human rabies prevention-United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2008, 57(RR-3):1-28.
-
(2008)
MMWR Recomm Rep
, vol.57
, Issue.3
, pp. 1-28
-
-
Manning, S.E.1
Rupprecht, C.E.2
Fishbein, D.3
-
80
-
-
0026590118
-
An outbreak of respiratory syncytial virus in a bone marrow transplant center
-
Harrington R.D., Hooton T.M., Hackman R.C., et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 1992, 165(6):987-993.
-
(1992)
J Infect Dis
, vol.165
, Issue.6
, pp. 987-993
-
-
Harrington, R.D.1
Hooton, T.M.2
Hackman, R.C.3
-
81
-
-
0029154365
-
Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients
-
Whimbey E., Champlin R.E., Englund J.A., et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant 1995, 16(3):393-399.
-
(1995)
Bone Marrow Transplant
, vol.16
, Issue.3
, pp. 393-399
-
-
Whimbey, E.1
Champlin, R.E.2
Englund, J.A.3
-
82
-
-
0034105067
-
Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin
-
Ghosh S., Champlin R.E., Englund J., et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant 2000, 25(7):751-755.
-
(2000)
Bone Marrow Transplant
, vol.25
, Issue.7
, pp. 751-755
-
-
Ghosh, S.1
Champlin, R.E.2
Englund, J.3
-
83
-
-
0032886187
-
Adverse effects of intravenous immunoglobulin therapy
-
Nydegger U.E., Sturzenegger M. Adverse effects of intravenous immunoglobulin therapy. Drug Saf 1999, 21(3):171-185.
-
(1999)
Drug Saf
, vol.21
, Issue.3
, pp. 171-185
-
-
Nydegger, U.E.1
Sturzenegger, M.2
-
84
-
-
0025840563
-
Enteral immunoglobulins for treatment of protracted rotaviral diarrhea
-
Guarino A., Guandalini S., Albano F., et al. Enteral immunoglobulins for treatment of protracted rotaviral diarrhea. Pediatr Infect Dis J 1991, 10(8):612-614.
-
(1991)
Pediatr Infect Dis J
, vol.10
, Issue.8
, pp. 612-614
-
-
Guarino, A.1
Guandalini, S.2
Albano, F.3
-
85
-
-
1642543876
-
Oral immunoglobulin treatment in Campylobacter jejuni enteritis
-
Hammarstrom V., Smith C.I., Hammarstrom L. Oral immunoglobulin treatment in Campylobacter jejuni enteritis. Lancet 1993, 341(8851):1036.
-
(1993)
Lancet
, vol.341
, Issue.8851
, pp. 1036
-
-
Hammarstrom, V.1
Smith, C.I.2
Hammarstrom, L.3
-
86
-
-
0031871760
-
Immunoglobulin replacement treatment by rapid subcutaneous infusion
-
Gaspar J., Gerritsen B., Jones A. Immunoglobulin replacement treatment by rapid subcutaneous infusion. Arch Dis Child 1998, 79(1):48-51.
-
(1998)
Arch Dis Child
, vol.79
, Issue.1
, pp. 48-51
-
-
Gaspar, J.1
Gerritsen, B.2
Jones, A.3
-
87
-
-
77950646691
-
Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load
-
Dennert R., Velthuis S., Schalla S., et al. Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load. Antivir Ther 2010, 15(2):193-201.
-
(2010)
Antivir Ther
, vol.15
, Issue.2
, pp. 193-201
-
-
Dennert, R.1
Velthuis, S.2
Schalla, S.3
-
88
-
-
21244459462
-
Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia
-
Mouthon L., Guillevin L., Tellier Z. Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia. Autoimmun Rev 2005, 4(5):264-269.
-
(2005)
Autoimmun Rev
, vol.4
, Issue.5
, pp. 264-269
-
-
Mouthon, L.1
Guillevin, L.2
Tellier, Z.3
-
89
-
-
0023299209
-
Chronic enteroviral meningoencephalitis in agammaglobulinemic patients
-
McKinney R.E., Katz S.L., Wilfert C.M. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis 1987, 9(2):334-356.
-
(1987)
Rev Infect Dis
, vol.9
, Issue.2
, pp. 334-356
-
-
McKinney, R.E.1
Katz, S.L.2
Wilfert, C.M.3
|